Public Access Records Office
The National Academies
500 5th Street NW
Room NAS 168
Washington, DC 20001
Tel: (202) 334-3543
FAX: (202) 334-2158
Email: paro@nas.edu
Project Information

Project Information


Reproductive Health Services: Assessing the Safety and Quality of Abortion Care in the U.S.


Project Scope:

In 1975, the Institute of Medicine (IOM) issued the report, Legalized Abortion and the Public Health: Report of a Study. The report contained a comprehensive analysis of the then available scientific evidence on the impact of abortion on the health of the public. Since 1975, there have been substantial changes in the U.S. healthcare delivery system and in medical science. In addition, practices for abortion care have changed, including the introduction of new techniques and technologies. An updated systematic and independent analysis of today’s available evidence has not been conducted. An ad hoc consensus committee of the Health and Medicine Division (HMD), which as of March 2016 continues the consensus studies and convening activities previously carried out by the IOM, will produce a comprehensive report on the current state of the science related to the provision of safe, high quality abortion services in the United States.


The committee will consider the following questions and offer findings and recommendations:

1) What types of legal abortion services are available in the United States? What is the evidence regarding which services are appropriate under different clinical circumstances (e.g., based on patient medical conditions such as previous cesarean section, obesity, gestational age)? 

2) What is the evidence on the physical and mental health risks of these different abortion interventions? 

3) What is the evidence on the safety and quality of medical and surgical abortion care?

4) What is the evidence on the minimum characteristics of clinical facilities necessary to effectively and safely provide the different types of abortion interventions? 

5) What is the evidence on what clinical skills are necessary for health care providers to safely perform the various components of abortion care, including pregnancy determination, counseling, and gestational age assessment, medication dispensing, procedure performance, patient monitoring, and follow-up assessment and care? 

6) What safeguards are necessary to manage medical emergencies arising from abortion interventions?

7) What is the evidence on the safe provision of pain management for abortion care?

8) What are the research gaps associated with the provision of safe, high quality care from pre-to post-abortion?

Status: Current

PIN: IOM-BPH-15-11

Project Duration (months): 18 month(s)

RSO: Eden, Jill


Committee Membership

Committee Post Date: 12/23/2016

Dr. Bruce N. Calonge - (Co-Chair) - (Co-Chair)
Bruce (Ned) Calonge, M.D., M.P.H., (co-chair), is President and CEO of The Colorado Trust, a private foundation dedicated to achieving health equity for all Coloradans. Prior to joining The Trust, he served as Chief Medical Officer of the Colorado Department of Public Health and Environment. Dr. Calonge also served as Chief of the Department of Preventive Medicine for the Colorado Permanente Medical Group and was a family physician for 10 years. Dr. Calonge's current academic appointments include Associate Professor of Family Medicine, Department of Family Medicine, University of Colorado Denver (UCD) School of Medicine; and Associate Professor of Epidemiology, UCD Colorado School of Public Health. Dr. Calonge serves on the Delta Dental of Colorado Foundation and LiveWell Colorado boards of directors. Nationally, Dr. Calonge is past Chair of the United States Preventive Services Task Force and a member of the Centers for Disease Control and Prevention's (CDC) Task Force on Community Preventive Services as well as the CDC’s Breast and Cervical Cancer Early Detection and Control Advisory Committee. He is Chair of the CDC's Evaluating Genomic Applications for Practice and Prevention (EGAPP) Workgroup, and is a consultant for and past member of the Advisory Committee on Heritable Disorders in Newborns and Children in the Maternal and Child Health Bureau in the Health Resources and Services Administration. Dr. Calonge serves on the Board on Population Health and Public Health Practice and the Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities in the Health and Medicine Division (HMD) of The National Academies. He has been board-certified in both Family Medicine and Preventive Medicine, and was elected to the NAM in 2011. Dr. Calonge earned an M.P.H. from the University of Washington and an M.D. from the University of Colorado.
Dr. Helene D. Gayle - (Co-Chair) - (Co-Chair)
Helene D. Gayle, M.D., M.P.H., (co-chair), is CEO of McKinsey Social Initiative, a nonprofit organization that implements programs that bring together varied stakeholders to address complex global social challenges. A member of the National Academy of Medicine, Dr. Gayle was previously president and CEO of CARE USA, a leading international humanitarian organization with approximately 10,000 staff whose poverty fighting programs reached over 97 million people in 87 countries. An expert on global development, humanitarian, and health issues, she also spent 20 years with the Centers for Disease Control (CDC), focused primarily on combating HIV/AIDS. She was appointed as the first director of the National Center for HIV, STD and TB Prevention, and achieved the rank of Rear Admiral and Assistant Surgeon General in the U.S. Public Health Service. Dr. Gayle also served as the AIDS coordinator and chief of the HIV/AIDS division for the U.S. Agency for International Development. Dr. Gayle then directed the HIV, TB and Reproductive Health Program at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues. She earned her M.D. at the University of Pennsylvania, and an M.P.H. at Johns Hopkins University. She is board certified in pediatrics.
Dr. Wendy R. Brewster
Wendy R. Brewster, M.D., Ph.D., is a gynecologic oncologist in the Department of Obstetrics and Gynecology and a professor of cancer epidemiology at the University of North Carolina (UNC), Chapel Hill. She is also the director of the UNC Center for Women’s Health Research. Dr. Brewster is a co-investigator for several projects designed to identify populations at risk for disparate treatment and poor outcomes in endometrial, colon, ovarian and cervical cancers. Her recent work has focused on the paradigm for treatment of gynecologic malignancies where obstacles to treatment exist for high-risk groups in limited resource areas. Prior to her move to UNC, Dr. Brewster was the director of the UC Irvine Gynecologic Oncology Fellowship Program. She received her M.D. and completed her residency in obstetrics and gynecology at the University of California, Los Angeles. Dr. Brewster completed a fellowship in gynecologic oncology and earned a Ph.D. in epidemiology at the University of California, Irvine.
Dr. Lee A. Fleisher
Lee A. Fleisher, M.D., is currently Professor and Chair of Anesthesiology at the University of Pennsylvania. His research includes perioperative risk assessment, perioperative quality metrics, and he has worked with Dr. Silber's group on grants related to template matching. He has been involved as a member and chair of Professional Society Guidelines and funded by both AHRQ and societies to perform evidence-based reviews. As a member of the IOM, he has worked with a committee to develop priorities for comparative effectiveness. He has been involved in developing performance metrics for both the American Society of Anesthesiologists and American College of Cardiology. He is Chair of the Consensus Standards Advisory Committee and co-chair of the Surgery Standing Committee of the National Quality Forum, and a member of the Administrative Board of the Council of Faculty and Academic Specialties of the Association of American Medical Colleges. He is also a member of the Medical Advisory Panel of the Technology Evaluation Center of the Blue Cross/Blue Shield Association.
Dr. Carol J. Hogue
Carol J. Hogue, Ph.D., M.P.H., is Professor of Epidemiology and Jules & Uldeen Terry Professor of Maternal and Child Health (MCH) at the Rollins School of Public Health of Emory University. She is also the Director of the Women's and Children's Center and the HRSA-sponsored Center of Excellence in MCH Education, Science, and Practice. A former Director of the federal Centers for Disease Control, Division of Reproductive Health (1988-92) and on faculties in Biometry at the University of Arkansas for Medical Science (1977-82) and the UNC School of Public Health Department of Biostatistics (1974-77), Dr. Hogue initiated many of the current CDC reproductive health programs, including the Pregnancy Risk Assessment Monitoring System, the National Pregnancy Mortality Surveillance System, and the National Infant Mortality Surveillance project that launched the national and state-level development and use of linked birth and death records. In addition, Dr. Hogue led the first research on maternal morbidities that was the precursor to the current safe motherhood initiative, and the initial innovative research on racial disparities in preterm delivery. She has published broadly in maternal health, including studies of long-term complications of induced abortion, ectopic pregnancy, stillbirth, unintended pregnancy, contraceptive failure, and reproductive cancers. Her current research projects include the Stillbirth Collaborative Research Network's population-based case-control study of stillbirth, an implementation fidelity study of elementary school-based health centers and a CDC-sponsored study of life course health of adolescents and adults living with congenital heart defects. Among her many honors, Dr. Hogue served as President of the Society for Epidemiologic Research (1988-89), served on the Institute of Medicine Committee on Unintended Pregnancy (1993-1995), was Chair of the Regional Advisory Panel for the Americas of the World Health Organization Human Reproduction Programme (1997-99), President of the American College of Epidemiology (2002-4), Senior Fellow of the Emory Center for the Study of Law and Religion (2001-6), and received the MCH Coalition’s National Effective Practice Award in 2002 and Greg Alexander Award for Advancing Knowledge.
Dr. Jody R. Lori
Jody R. Lori, Ph.D., M.S., C.N.M., FACNM, FAAN, is a Certified Nurse Midwife. She is a Clinical Assistant Professor and the Associate Dean for Global Affairs and World Health Organization (WHO) Collaborating Center Director at the University of Michigan School of Nursing. Her program of research centers on community-based interventions to address the high rates of maternal and neonatal mortality in sub-Saharan Africa. Currently, she is working in collaboration with the American College of Nurse-Midwives (ACNM) on a major multi-year project addressing midwifery pre-service education and faculty retention in Ghana and Cambodia. Her research in Ghana is focused on describing pathways for posting professional midwives to underserved and deprived rural areas to encourage rural service for the Ministry of Health. Past field work experience has included travel to Ghana, Guatemala, Ethiopia, Liberia, Mexico and Zambia. Dr. Lori has taught numerous courses focused on global health, health promotion, risk reduction, and integrating midwifery practices in global settings. She earned her Bachelor and Master of Science in Nursing at the University of Michigan and a Ph.D. in Nursing at the University of Arizona.
Dr. Jeanne Miranda
Jeanne Miranda, Ph.D., M.S., is a Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA. She is a mental health services researcher who has focused her work on providing mental health care to low-income and minority communities. Dr. Miranda's major research contributions have been in evaluating the impact of mental health care for ethnic minority communities. She is currently working with two community partners, TIES for Families and the Center for Adoption Support and Education to evaluate an intervention her team developed to provide care for families adopting older children from foster care. She is also working to develop appropriate depression interventions for young women in Uganda and evaluating a government micro-finance program in Uganda. Dr. Miranda is an investigator in two UCLA centers focusing on improving disparities in health care for ethnic minorities. She is a member of the National Academy of Medicine and a recipient of the Emily Mumford Award for Contributions to Social Medicine from Columbia University. She holds a Ph.D. in Clinical Psychology from University of Kansas and completed post-doctoral training at University of California, San Francisco.
Dr. Ruth M. Parker
Ruth Parker, M.D., is Professor of Medicine and Associate Director of Faculty Development for the Division of General Medicine at the Emory University School of Medicine. She holds secondary appointments in pediatrics and in epidemiology at the University’s Rollins School of Public Health. Her primary research interests and activities are in medical education and health services of underserved populations (particularly health literacy). She recently completed a position as Chair NDAC (non-prescription drug advisory committee) for the U.S. Food and Drug Administration (FDA), the committee that reviews all drug applications for the switch from prescription to over-the-counter status. She served as the expert in label comprehension for this group, and frequently works with various FDA Advisories representing issues related to health literacy and patient/consumer understanding of drug information. She is a member of a PCORI Advisory group and serves on an Expert Panel for the USPharmacopeia. Dr. Parker was principal investigator in the Robert Wood Johnson Literacy in Health Study, and worked with collaborators to develop the Test of Functional Health Literacy in Adults (TOFHLA), a measurement tool to quantify patients' ability to read and understand health information. She chaired the American Medical Association Foundation steering committee for the national program on health literacy and also chaired the American College of Physicians Foundation Patient Literacy Advisory Board. Dr. Parker consults with various federal agencies (including the Department of Education, the office of the Surgeon General, the NIH, the CDC, HRSA, AHRQ) for proposals and organizational issues related to health literacy. She works closely with professional societies on their efforts to advance health literacy, and has consulted with numerous members of industry (including large health care provider organizations, chain drug stores, and members of the pharmaceutical industry) regarding their efforts to improve health literacy. Dr. Parker earned her M.D. at the University of North Carolina, Chapel Hill. She holds Board Certification in both Internal Medicine and Pediatrics.
Dr. Deborah E. Powell
Deborah E. Powell, M.D., is Dean Emeritus of the medical school, and professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota. She joined Minnesota in 2002 and led the University of Minnesota Medical School until 2009. She was also Assistant Vice President for Clinical Sciences, Associate Vice-President for New Models of Education and McKnight Presidential leadership Chairman at University of Minnesota, Twin Cities. Prior to coming to Minnesota, she served as an Executive Dean and Vice Chancellor for Clinical Affairs at the University of Kansas School of Medicine for 5 years. Previously, she served as Chairman of the Department of Pathology and Laboratory Medicine and as Vice Chairman and Director of Diagnostic Pathology at the University of Kentucky in Lexington. She is a medical educator and has more than 30 years’ experience in academic medicine. Additionally, she has been the President of the United States and Canadian Academy of Pathology and the President of the American Board of Pathology. She served as the Chairman of the Council of Deans of the Association of American Medical Colleges and as Chair of the Association of American Medical Colleges in 2009-2010. She has served as a Director of the Accreditation Council for Graduate Medical Education, the Institute for Healthcare Improvement, Fairview Health System, the University of Minnesota Medical Center, Association of American Medical Colleges and Hazelden. She is a Member of the National Academy of Medicine. Dr. Powell is a board-certified Surgical Pathologist. She received her Medical Degree from Tufts University School of Medicine.
Dr. Eva K. Pressman
Eva K. Pressman, M.D., is the Henry A. Thiede Professor and Chair of the Department of Obstetrics and Gynecology at the University of Rochester. She formerly served as Director of Maternal Fetal Medicine (MFM), Director of the MFM Fellowship training program, Director of Reproductive Genetics, and Director of OB/GYN Ultrasound. Before coming to Rochester in 1999, Dr. Pressman was an Assistant Professor at Johns Hopkins from 1994-1999, where she was also Associate Director of the OB/GYN Residency Program, Director of the Fetal Assessment Center, and of the High Risk Obstetrical Clinic. Dr. Pressman is Board Certified in OB/GYN and in Maternal Fetal Medicine. Her current areas of interest include medical complications of pregnancy including diabetes and psychiatric disorders and nutrition and metabolism in pregnancy. She received her medical degree at Duke University School of Medicine, where she was elected to Alpha Omega Alpha Honor Society. Dr. Pressman did her residency training in OB/GYN as well as a fellowship in Maternal Fetal Medicine at The Johns Hopkins University.
Dr. Michael L. Raggio
Michael L. Raggio, M.D., is an obstetrician/gynecologist and former Senior Physician Director of Quality, Risk, and Safety with the Colorado Permanente Medical Group, an 1100-physician group that works exclusively with Kaiser Foundation Health Plan of Colorado (KP Colorado). Dr. Raggio has more than 30 years of clinical experience in obstetrics and gynecology. In his 23-year tenure as Physician Director of Quality for KP Colorado, he co-managed NCQA readiness, 30 clinical department-based peer review committees, and quality and patient safety improvement consultation for the Denver region and the larger national Kaiser Permanente program. Dr. Raggio was a founding reviewer for the KP Medical Directors Quality Review, an internal standards-based quality review, since its inception in 1994. He served on the Colorado Medical Board for 4 years. Dr. Raggio is certified by the American Board of Medical Quality. Earlier in his career, he chaired the OB/GYN Quality Assurance Committee at Saint Joseph Hospital (Denver) and the OB/GYN Department Quality Committee at KP Colorado. Now retired, he consults in the areas of patient safety, quality measurement and improvement, practitioner performance assessment and improvement, governance, and medical and institutional ethics. Dr. Raggio earned his M.D. at the Baylor College of Medicine.
Dr. Alina Salganicoff
Alina Salganicoff, Ph.D., is Vice President and Director of Women’s Health Policy at the Kaiser Family Foundation. Widely regarded as an expert on women’s health policy, she has written and lectured extensively on health care access and financing for low-income women and children. Her work at the Foundation focuses on health coverage and access to care for women, with an emphasis on challenges facing underserved women throughout their lifespan. Dr. Salganicoff was also an Associate Director of the Kaiser Commission on Medicaid and the Uninsured and worked on the health program staff of the Pew Charitable Trusts. She has been a member of numerous federal, state, and non-profit advisory committees. Dr. Salganicoff holds a Ph.D. in Health Policy from The Johns Hopkins University and a B.S. from Penn State.
Dr. Paul Shekelle
Paul G. Shekelle, M.D., Ph.D., M.P.H., is the co-director of the Southern California Evidence-based Practice Center at the RAND Corporation. He is a staff physician in internal medicine at the West Los Angeles Veterans Affairs Medical Center and also a professor of medicine at the University of California, Los Angeles (UCLA) School of Medicine. Dr. Shekelle is a past chair of the Clinical Guidelines Committee of the American College of Physicians. He earned his M.D. from Duke University and his Ph.D. from UCLA.
Ms. Susan M. Wolf
Susan M. Wolf, J.D., is the McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law; and Professor of Medicine at the University of Minnesota. She is also Chair of the University's Consortium on Law and Values in Health, Environment & the Life Sciences. Professor Wolf teaches in the areas of health law, law and science, and bioethics. She is a member of the National Academy of Medicine (NAM), a fellow of the American Association for the Advancement of Science (AAAS), and a member of the American Law Institute (ALI). She has served on a variety of governmental and institutional panels, including the National Science Advisory Board for Biosecurity, American Bar Association Coordinating Group on Bioethics and the Law, American Society for Reproductive Medicine Ethics Committee, New York City AIDS Review Panel, and Memorial Sloan-Kettering Cancer Center Ethics Committee. Professor Wolf currently serves on the National Academies Committee on Science, Engineering, Medicine and Public Policy. She is a past chair of the Association of American Law Schools Section on Law, Medicine & Health Care and a past board member of the American Society for Bioethics and Humanities. She received her J.D. from Yale Law School.


Committee Membership Roster Comments

Note: There was a change in the Committee Membership with the resignation of Michael L. Raggio effective 04/19/2017 (April 19, 2017).

Events



Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Ned Calonge (co-chair)
Helene Gayle (co-chair)
Wendy Brewster
Lee Fleisher
Carol Hogue
Jody Rae Lori
Jeanne Miranda
Ruth Parker
Deborah Powell
Eva Pressman
Alina Salganicoff
Paul Shekelle
Susan Wolf (via teleconference)


The following topics were discussed in the closed sessions:

• Report chapter edits and changes
• Report chapter responsibilities
• Findings, conclusions, and recommendations
• Report review process and timeline
• Additional research needed


The following materials (written documents) were made available to the committee in the closed sessions:

• Report chapter drafts

Date of posting of Closed Session Summary:
August 09, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician affiliated with a large health care organization that provides abortions and other reproductive health services to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee spoke by teleconference with a clinician who serves as Chief Medical Officer of a large health care organization that provides abortions and other reproductive health services. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

Date of posting of Closed Session Summary:
July 26, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Ned Calonge (co-chair)
Helene Gayle (co-chair)
Wendy Brewster
Lee Fleisher
Carol Hogue
Ruth Parker
Debbie Powell
Eva Pressman
Alina Salganicoff
Paul Shekelle
Susan Wolf

The following topics were discussed in the closed sessions:

•Draft chapters, comments, and edits
•Report gaps, findings and conclusions

The following materials (written documents) were made available to the committee in the closed sessions:

•Draft chapters
•Draft findings, conclusions, gaps, and recommendations

Date of posting of Closed Session Summary:
July 26, 2017


Location:

Conference call
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

All members attended through conference call:
Ned Calonge (co-chair)
Helene Gayle (co-chair)
Wendy Brewster
Lee Fleisher
Carol Hogue
Jody Lori
Jeanne Miranda
Ruth Parker
Eva Pressman
Alina Salganicoff
Paul Shekelle
Susan Wolf


The following topics were discussed in the closed sessions:

•Report chapter reviews and edits
•Report findings and conclusions

The following materials (written documents) were made available to the committee in the closed sessions:

•Drafts of selected sections of the report

Date of posting of Closed Session Summary:
June 29, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee met with a clinician who provides abortions to learn the clinician's perspective on the key elements of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

Date of posting of Closed Session Summary:
June 12, 2017


Location:

Arnold and Mabel Beckman Center
100 Academy Dr.
Irvine, California
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Ned Calonge (co-chair)
Helene Gayle (co-chair
via teleconference)
Wendy Brewster
Lee Fleisher
Carol Hogue
Jody Rae Lori (via teleconference May 16 only)
Jeanne Miranda
Ruth Parker
Deborah Powell
Eva Pressman
Alina Salganicoff
Paul Shekelle
Susan Wolf (May 17 only)


The following topics were discussed in the closed sessions:

• Report outline organization
• Preliminary findings and conclusions
• Report chapter responsibilities
• Additional supporting research and literature search needed

The following materials (written documents) were made available to the committee in the closed sessions:

• Literature search strategies
• Terms and definitions

Date of posting of Closed Session Summary:
May 22, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee met with a clinician who provides abortions to learn the clinician's perspective on the key elements of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

Date of posting of Closed Session Summary:
April 12, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee met with a clinician who provides abortions and trains abortion providers to learn the clinician's perspective on the key elements of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

Date of posting of Closed Session Summary:
April 12, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview an expert in family planning education to gain perspective on training issues related to the assurance of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee met with an expert in family planning education to gain perspective on training issues related to the assurance of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; medical school program requirements (related to abortion); OBGYN and Family Medicine residency requirements (related to abortion); and future research priorities.

Date of posting of Closed Session Summary:
April 12, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee met with a clinician who provides abortions and trains abortion providers to learn the clinician's perspective on the key elements of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

Date of posting of Closed Session Summary:
April 12, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Reproductive Health Services Project Staff
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
AGENDA - please note that this agenda is subject to change.

KECK 100

8:30 AM
Welcome and Introductory Remarks—Ned Calonge, M.D., Committee Co-Chair

8:40
Meeting Accreditation and State Licensing Requirements: The Experiences of Provider Organizations
—Juliet Rogers, Ph.D., M.P.H., Assistant Professor, Health Management and Policy, University of Michigan
Q & A/Discussion

9:20
Differences in Facility Standards: Abortions and Other Outpatient Procedures
—Bonnie Scott Jones, J.D., Senior Policy Advisor at Advancing New Standards in Reproductive Health (ANSIRH), University of California, San Francisco
Q & A/Discussion

10:00
Research on the Relationship of Facility-Related Factors and Patient Outcomes for Non-Hospital-Based Outpatient Procedures
—Sarah Roberts, Dr.P.H., Associate Professor, Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco
Q & A/Discussion

10:45 - Break

11:00 - Public comments (3-5 minutes each)
Q & A/Discussion

12:00 PM - Closing Remarks—Helene Gayle, M.D., Committee Co-Chair

12:10 - ADJOURN

PUBLIC COMMENTS
From 11:00 AM to 12:00 PM, the meeting will be open for public comment on issues related to facility standards and the safety of outpatient abortion services. You may submit comments in writing (via email) or in-person. To do so, please note the following:

1. To comment in-person, please email your comments in advance to: reproductivehealth@nas.edu.
2. Requests to address the committee in-person will be accepted until noon on Wednesday, March 22.
3. Only comments related to the topic of the workshop will be considered.
4. Comments should be submitted along with your name and affiliation.
5. We will accommodate as many in-person testimonies as time allows. First come, first serve.
6. Can’t attend the meeting in person? That’s okay! Email your written comments to the above address—they will be shared with the committee.

PLEASE NOTE: Any comments you submit to the committee, including your name and identifying information, will be posted in a Public Access File in accordance with Section 15 of the Federal Advisory Committee Act (FACA). The National Academies shall be authorized to use any such comments or submissions in accordance with the National Academies' Terms of Use Statement.

To register to attend this meeting in person: http://www.surveygizmo.com/s3/3397015/rhsmarch24workshop
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Ned Calonge (co-chair)
Helene Gayle (co-chair)
Wendy Brewster (March 23 only)
Lee Fleisher
Carol Hogue
Jody Rae Lori
Jeanne Miranda
Ruth Parker
Deborah Powell
Eva Pressman
Michael Raggio
Alina Salganicoff
Paul Shekelle
Susan Wolf (via teleconference)


The following topics were discussed in the closed sessions:

• Open session (March 24) speaker presentations
• Report timeline
• Report outline and chapter work groups
• Research/literature goals, potential research gaps


The following materials (written documents) were made available to the committee in the closed sessions:

• Literature search strategies
• Handouts of presentation slides
• Draft causal model
• Findings, conclusions, and recommendations guidelines
• Fact-checking guidelines
• Report chapter draft
• Discussion guide for provider interviews
• Blau, M. A provocative abortion clinic opens in the Bible Belt, with no apologies. 20 March 2017. STAT.


Date of posting of Closed Session Summary:
April 03, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Three members of the Reproductive Health Services Committee met with a clinician who provides abortions, trains abortion providers, and operates an outpatient abortion clinic to learn the clinician's perspective on the key elements of high quality, safe abortion care. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

The following materials (written documents) were made available to the committee in the closed sessions:

N/A

Date of posting of Closed Session Summary:
March 21, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  -
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  -

Agenda
Members of the Reproductive Health Services Committee will interview a clinician who provides abortions to gain perspective on the key elements of high quality, safe abortion care.
Is it a Closed Session Event?
Yes

The following topics were discussed in the closed sessions:

Two members of the Reproductive Health Services Committee spoke by teleconference with an obstetrician/gynecologist who directs family planning services and physician training at a large academic medical center. Issues discussed on this call included factors that may diminish or improve the safety and quality of medical and surgical abortions (i.e. clinical setting, provider skills and training, pain management, and linkages to local health care providers); necessary precautions for patients with comorbidities and other special considerations; patient preferences; FDA REMS requirements; psychological needs of patients; delays in abortion care; and future research priorities.

The following materials (written documents) were made available to the committee in the closed sessions:

N/A

Date of posting of Closed Session Summary:
March 21, 2017


Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Katye Magee
Contact Email:  reproductivehealth@nas.edu
Contact Phone:  202-334-2353

Agenda
January 9, 2017

CLOSED SESSION - 8:15 AM – 12:15 PM

OPEN SESSION - 12:15 PM - 1:15 PM

12:15 PM Discussion of Scope of Task with Sponsors

Welcome and Introductory Remarks, Helene Gayle and Ned Calonge, Co-Chairs

Sponsor comments

1:15 PM Adjourn

BEGIN CLOSED SESSION - 1:15 PM

January 10, 2017 - CLOSED SESSION
Is it a Closed Session Event?
Yes

Closed Session Summary Posted After the Event

The following committee members were present at the closed sessions of the event:

Ned Calonge
Wendy Brewster
Lee Fleisher
Helene Gayle
Carol Hogue
Jody Rae Lori
Jeanne Miranda
Ruth Parker
Eva Pressman
Alina Salganicoff
Paul Shekelle
Susan Wolf

The following topics were discussed in the closed sessions:

• Completed orientation on the HMD consensus study process
• Completed the committee conflict of interest and bias discussion for those present
• Discussed statement of task
• Identified working groups, information needs, and data gathering methods
• Developed preliminary work plan and rough report outline
• Reviewed project timeline
• Deliberated topics and panels for March public workshop

The following materials (written documents) were made available to the committee in the closed sessions:

• Study timeline
• Handouts of presentation slides
• Preliminary report draft
• Working group assignments

Date of posting of Closed Session Summary:
January 18, 2017

Publications

  • Publications having no URL can be seen at the Public Access Records Office